Schedule 13D ownership disclosure

CESCA THERAPEUTICS INC.

Security class unavailable · CUSIP: 157131103

Event date: 2016-11-03

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,102,941
Percent of class
62.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001683168-16-000483
Form type
SC 13D/A
Filer
Boyalife Investment Inc.
CIK
CIK 1667750
Filed
Nov 04, 2016
Reporting period
Nov 03, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub